Evidence map›Paper›PMID 29451412›Full record

ArticleThe British journal of radiology2018

Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study.

Ralph Th Leijenaar, Marta Bogowicz, Arthur Jochems, Frank Jp Hoebers, Frederik Wr Wesseling, Sophie H Huang, Biu Chan, John N Waldron, Brian O'Sullivan, Derek Rietveld and 7 more

Open access · hybridAbstract readMulticenter StudyValidation Study
In one paragraph

Article in The British journal of radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 3 pooled it
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 3 syntheses or guidelines pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Imaging the hallmarks of cancer.Nature reviews. Cancer · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Ralph Th Leijenaar1 The D-Lab: Decision Support for Precision Medicine GROW - School for Oncology and Developmental Biology & MCCC Maastricht University Medical Centre+ Maastricht , Maastricht , Netherlands.
Marta Bogowicz2 Department of Radiation Oncology, University Hospital Zurich and University of Zurich , Zurich , Switzerland.
Arthur Jochems1 The D-Lab: Decision Support for Precision Medicine GROW - School for Oncology and Developmental Biology & MCCC Maastricht University Medical Centre+ Maastricht , Maastricht , Netherlands.
Frank Jp Hoebers3 Department of Radiation Oncology, GROW- School for Oncology and Developmental Biology, Maastricht University Medical Centre , Maastricht , Netherlands.
Frederik Wr Wesseling3 Department of Radiation Oncology, GROW- School for Oncology and Developmental Biology, Maastricht University Medical Centre , Maastricht , Netherlands.
Sophie H Huang4 Department of Radiation Oncology, Princess Margaret Cancer Center, University of Toronto , Toronto, Ontario , Canada.
Biu Chan4 Department of Radiation Oncology, Princess Margaret Cancer Center, University of Toronto , Toronto, Ontario , Canada.
John N Waldron4 Department of Radiation Oncology, Princess Margaret Cancer Center, University of Toronto , Toronto, Ontario , Canada.
Brian O'Sullivan4 Department of Radiation Oncology, Princess Margaret Cancer Center, University of Toronto , Toronto, Ontario , Canada.
Derek Rietveld5 Department of Radiation Oncology, VU University Medical Center , Amsterdam , Netherlands.
C Rene Leemans6 Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center , Amsterdam , Netherlands.
Ruud H Brakenhoff6 Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center , Amsterdam , Netherlands.
Oliver Riesterer2 Department of Radiation Oncology, University Hospital Zurich and University of Zurich , Zurich , Switzerland.
Stephanie Tanadini-Lang2 Department of Radiation Oncology, University Hospital Zurich and University of Zurich , Zurich , Switzerland.
Matthias Guckenberger2 Department of Radiation Oncology, University Hospital Zurich and University of Zurich , Zurich , Switzerland.
Kristian Ikenberg7 Institute of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich , Zurich , Switzerland.
Philippe Lambin1 The D-Lab: Decision Support for Precision Medicine GROW - School for Oncology and Developmental Biology & MCCC Maastricht University Medical Centre+ Maastricht , Maastricht , Netherlands.
Maastricht University Medical Centre · NLAmsterdam UMC Location VUmc · NLUniversity Hospital of Zurich · CHUniversity of Toronto · CAUniversity of Zurich · CHPrincess Margaret Cancer Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHuman papillomavirus (HPV) positive oropharyngeal cancer (oropharyngeal squamous cell carcinoma, OPSCC) is biologically and clinically different from HPV negative OPSCC. Here, we evaluate the use of a radiomic approach to identify the HPV status of OPSCC.

methodsFour independent cohorts, totaling 778 OPSCC patients with HPV determined by p16 were collected. We randomly assigned 80% of all data for model training (N = 628) and 20% for validation (N = 150). On the pre-treatment CT images, 902 radiomic features were calculated from the gross tumor volume. Multivariable modeling was performed using least absolute shrinkage and selection operator. To assess the impact of CT artifacts in predicting HPV (p16), a model was developed on all training data (M

resultsThe area under the receiver operator curve for M

conclusionThis study provides proof of concept that molecular information can be derived from standard medical images and shows potential for radiomics as imaging biomarker of HPV status. Advances in knowledge: Radiomics has the potential to identify clinically relevant molecular phenotypes.

Indexed as

Tomography, X-Ray ComputedBiomarkersCarcinoma, Squamous CellCyclin-Dependent Kinase Inhibitor p16HumansImage Processing, Computer-AssistedKaplan-Meier EstimateOropharyngeal NeoplasmsPapillomaviridaeProportional Hazards ModelsBiomarkersCyclin-Dependent Kinase Inhibitor p16

Identifiers

PMID29451412
PMCPMC6223271
OpenAlexW2788899656

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.